American CryoStem Announces the Addition of John Schwartz, PhD to Its Advisory Board - NewsBreak

EATONTOWN, NJ / ACCESSWIRE / November 23, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a leading clinical-stage biotechnology developer of adipose tissue-based cellular technologies for Regenerative and Personalized Medicine announced today that it has added John 'Jay' Schwartz, PhD to its Scientific and Medical Advisory Board. Dr. Schwartz, who...